A diabetes drug called liraglutide might help protect cartilage by slowing down the breakdown of joint tissue in lab-grown mouse cells.

12

Pro

0

Against

Evidence from Studies

Supporting (1)

12

Community contributions welcome

12

Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis

Cross-Sectional Study

Animal

2022 Jan 28

The study shows that liraglutide helps protect cartilage by reducing harmful enzymes in lab-grown joint cells, which supports the main idea of the claim.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis

Score: 12

DOI: 10.1038/s41598-022-05323-7

Similar Assertions

In stressed cartilage cells from rats, the diabetes drug liraglutide seems to lower the activity of harmful enzymes that break down cartilage, which might help protect joints when the body is under metabolic stress.

8

0

86%

A diabetes drug called liraglutide might help calm down inflammation in joint cells and immune cells in mice, especially at certain doses.

12

0

83%

Some diabetes drugs like liraglutide and exenatide might help protect cartilage in arthritic joints by slowing down the breakdown of important joint components.

26

0

80%

Liraglutide might help protect cartilage cells from dying when they're under stress, at least in lab studies with rat cells.

8

0

77%

When rat cartilage cells are stressed by sugar-related toxins, the diabetes drug liraglutide seems to calm down inflammation — suggesting it might help protect joints in conditions like diabetes.

8

0

77%